TGen is a trailblazing genomics research institute that was established on February 7, 2002 by a group of visionary leaders in the fields of science, medicine, government, and business. Their mission was to position Arizona as a major player in the biotechnology industry's new economy. Led by internationally recognized scientist Dr.

Jeffrey Trent, TGen is home to some of the world's top scientists who are dedicated to translating groundbreaking genetic research into tangible medical advancements for the benefit of patients and their families. TGen's extensive research and services encompass a wide range of areas, including cancer, neurological disorders, pathogen and microbiome studies, and rare childhood disorders. They also conduct clinical trials and actively encourage participation in their research initiatives.

Additionally, TGen offers educational and outreach programs, such as the Helios Scholars program and the TGen Bioscience Leadership Academy, to develop the next generation of scientific leaders. Through their tireless efforts, TGen is revolutionizing the field of genomics and paving the way for innovative breakthroughs that have the potential to transform healthcare on a global scale